76
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?

ORCID Icon, , , , & ORCID Icon
Pages 1809-1815 | Published online: 23 Oct 2019

References

  • Wharton W, Goldstein FC, Tansey MG, et al. Rationale and design of the mechanistic potential of antihypertensives in preclinical Alzheimer’s (HEART) trial. J Alzheimers Dis. 2018;61:1–10. doi:10.3233/JAD-17062829103038
  • Dacks PA, Armstrong JJ, Brannan SK, et al. A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline. Alzheimers Res Ther. 2016;8:33. doi:10.1186/s13195-016-0200-327543171
  • Van Middelaar T, van Nught LA, van Gool WA, et al. Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis. J Hypertens. 2018;36:1780–1787.29927845
  • Rouch L, Cestac P, Hanon O, et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs. 2015;29:113–130. doi:10.1007/s40263-015-0230-625700645
  • Levi Marpillat N, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31:1073–1082. doi:10.1097/HJH.0b013e3283603f5323552124
  • Hajjar I, Levey A. Association between angiotensin receptor blockers and longitudinal decline in tau in mild cognitive impairment. JAMA Neurol. 2015;72:1069–1070. doi:10.1001/jamaneurol.2015.100126368351
  • Hajjar I, Brown L, Mack WJ, Chui H. Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol. 2012;69:1632–1638.22964777
  • Fournier A, Oprisiu-Fournier R, Serot JM, et al. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors. Expert Rev Neurother. 2009;9:1413–1431. doi:10.1586/ern.09.8919769454
  • Wang J, Ho L, Chen L, et al. Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest. 2007;117:3393–3402. doi:10.1172/JCI3154717965777
  • Li J, Culman J, Hörtnagl H, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 2005;19:617–619. doi:10.1096/fj.04-2960fje15665034
  • Faure S, Chapot R, Tallet D, Javellaud J, Achard JM, Oudart N. Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors. J Physiol Pharmacol. 2006;57:329–342.17033088
  • Kehoe PG. The coming of age of the angiotensin hypothesis in Alzheimer’s disease: progress toward disease prevention and treatment? J Alzheimers Dis. 2018;62:1443–1466. doi:10.3233/JAD-17111929562545
  • Wiesmann M, Roelofs M, van der Lugt R, Heerschap A, Kiliaan AJ, Claassen JA. Angiotensin II, hypertension and angiotensin II receptor antagonism: roles in the behavioural and brain pathology of a mouse model of Alzheimer’s disease. J Cereb Blood Flow Metab. 2017;37:2396–2413. doi:10.1177/0271678X1666736427596834
  • Barthold D, Joyce G, Wharton W, Kehoe P, Zissimopoulos J, Shimosawa T. The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity. PLoS ONE. 2018;13(11):e0206705. doi:10.1371/journal.pone.020670530383807
  • Marcum ZA, Hohl SD, Gray SL, Barthold D, Crane PK, Larson EB. Patient perceptions of antihypertensive use as a dementia prevention strategy: a mixed-method analysis of a web-based survey. J Alzheimers Dis. 2019;68:523–529. doi:10.3233/JAD-18108030814348
  • Marcum ZA, Hohl SD, Gray SL, Barthold D, Crane PK, Larson EB. Brain health and dementia prevention: a mixed-method analysis. Am J Health Behav. 2019;43:300–310. doi:10.5993/AJHB.43.2.730808470
  • Girdler-Brown BV, Dzikiti LN. Hypothesis tests for the difference between two population proportions using Stata. South Afr J Pub Health. 2018;2:63–68.
  • Hajjar I. Postural blood pressure changes and orthostatic hypotension in the elderly patient. Drug and Aging. 2005;22(1):55–68. doi:10.2165/00002512-200522010-00004
  • Aikens JE, Nease DE, Klinkman MS. Explaining patients’ beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med. 2008;6:23–29. doi:10.1370/afm.75918195311
  • Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007;26:40–49. doi:10.1037/0278-6133.26.1.4017209696
  • Mishra SI, Gioia D, Childress S, Barnet B, Webster RL. Adherence to medication regimens among low-income patients with multiple comorbid chronic conditions. Health Soc Work. 2011;36:249–258. doi:10.1093/hsw/36.4.24922308877